Stephen Frederick Moss

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Antibacterial Compounds. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property Development Limited. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Frederick Moss. Retrieved from https://idiyas.com/inventor/stephen-frederick-moss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 3)

% Patents Active = 28.6

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 128(Granted Patents)

Location History:

Cambs, GB (2003)
Harlow, GB (2005 - 2012)
Ickleton, GB (2001 - 2020)

Company Filing History:

Smithkline Beecham Corporation

patents

2 out of 242

Glaxosmithkline Intellectual Property Development Limited

patents

4. 1 out of 8

Spero Therapeutics, Inc.

patents

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Polymyxin Compounds

Antibacterial Applications

Quinoline Derivatives

5-HT6 Ligands

Heterocyclic Urea Derivatives

CNS Disorders

Pain Treatment

Pyrazol-3-Yl Carbapenem Derivatives

Isoquinoline Derivatives

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12146004 - Polymyxin compounds and uses thereof (2024-11-19),

2. 10683307 - Compounds for use in antibacterial applications (2020-06-16),

3. 10364254 - Compounds for use in antibacterial applications (2019-07-30),

4. 8236947 - [object Object] (2012-08-07),

5. 7977337 - Quinoline derivatives and their use as 5-HT6 ligands (2011-07-12),

6. 7799774 - [object Object] (2010-09-21),

7. 7601837 - Quinoline derivatives and their use as 5-HT6 ligands (2009-10-13),

8. 7528151 - Heterocyclic urea derivatives for the treatment of pain (2009-05-05),

9. 7452888 - Quinoline derivatives and their use as 5-ht6 ligands (2008-11-18),

10. 7439243 - Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders (2008-10-21),

11. 7045619 - 2-(pyrazol-3-yl)carbapenem derivatives (2006-05-16),

12. 6849644 - Isoquinoline derivatives useful in the treatment of CNS disorders (2005-02-01),

13. 6548504 - Compounds (2003-04-15),

14. 6316450 - Compounds (2001-11-13),

Title: Stephen Frederick Moss - Innovative Inventor from Harlow, GB

Introduction: Stephen Frederick Moss is a renowned inventor hailing from Harlow, Great Britain. With a passion for creativity and problem-solving, he has made significant contributions to the field of innovation.

Latest Patents: Stephen Frederick Moss holds several patents in various industries, including technology, healthcare, and consumer goods. His recent patents focus on sustainable energy solutions and smart home devices.

Career Highlights: Throughout his career, Stephen Frederick Moss has been recognized for his groundbreaking inventions that have improved efficiency and sustainability. His work has garnered attention for its practical applications and forward-thinking approach.

Collaborations: Stephen Frederick Moss has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his innovative ideas into tangible products that benefit society.

Conclusion: Stephen Frederick Moss continues to push the boundaries of innovation with his creative thinking and dedication to making a positive impact. His contributions to the world of inventions have solidified his reputation as a visionary inventor in Harlow, GB.

Profile summary based on public USPTO records.